Creative Financial Designs’s Iovance Biotherapeutics IOVA Stock Holding History

Creative Financial Designs’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23,190	Closed	-$172K	–	2089
2024 Q4	$172K	Buy	23,190 +1,450	+7%	+$13.4K	0.01%	481
2024 Q3	$204K	Buy	21,740 +8,090	+59%	+$76.6K	0.02%	445
2024 Q2	$109K	Buy	13,650 +9,250	+210%	+$99.1K	0.01%	569
2024 Q1	$65.2K	Buy	+4,400	New	+$51.2K	0.01%	663
2020 Q1	–	Sell	-9	Closed	–	–	535
2019 Q4	$0	Hold	9	–	–	﹤0.01%	581
2019 Q3	$0	Hold	9	–	–	﹤0.01%	640
2019 Q2	$0	Hold	9	–	–	﹤0.01%	573
2019 Q1	$0	Hold	9	–	–	﹤0.01%	602
2018 Q4	$0	Hold	9	–	–	﹤0.01%	670
2018 Q3	$0	Hold	9	–	–	﹤0.01%	782
2018 Q2	$0	Buy	+9	New	+$132	﹤0.01%	770

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Creative Financial Designs's IOVA Position: Q1 2025 in Review

Creative Financial Designs sold out of Iovance Biotherapeutics (IOVA) in Q1 2025, closing a stake of 23,190 shares — an estimated $172K sold.

Creative Financial Designs first reported a position in IOVA in Q2 2018 and held it in 11 quarters. The position peaked at $204K in Q3 2024. 302 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.

Creative Financial Designs reported no remaining Iovance Biotherapeutics position as of Q1 2025 after selling out during the quarter.
Creative Financial Designs sold 23,190 Iovance Biotherapeutics shares in Q1 2025, an estimated $172K.
Creative Financial Designs first reported a position in Iovance Biotherapeutics in Q2 2018 and held it in 11 quarters.
Creative Financial Designs's Iovance Biotherapeutics position peaked at $204K in Q3 2024.
302 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.

Based on Creative Financial Designs's 13F filing for Q1 2025, filed 23 Apr 2025.